Browsing Tag
ANKTIVA
3 posts
Saudi Arabia becomes next test for whether ANKTIVA can scale beyond U.S. oncology markets
ImmunityBio Inc. launches ANKTIVA in Saudi Arabia with pricing approval and regional partners. Find out why this move matters for global oncology strategy.
ImmunityBio (NASDAQ: IBRX) secures Saudi FDA approval for ANKTIVA in BCG-unresponsive bladder cancer
ImmunityBio secures Saudi approval for ANKTIVA in NMIBC. Find out how this reshapes the company’s MENA strategy and immunotherapy ambitions.
ImmunityBio, BeiGene launch Phase 3 Trial to advance lung cancer immunotherapy
ImmunityBio, Inc. (NASDAQ: IBRX) has entered into a collaboration and supply agreement with BeiGene, Ltd., a global oncology…